ARTG Entry

RILPEMVI

ARTG entry for RILPEMVI (emtricitabine), ARTG 506406 — Product Information, dosage form, registration history. Compiled by arcimedes.

• Sponsor: Lupin
• Active ingredient: emtricitabine
• Therapeutic area: Infectious Disease

TGA Public Summary — ARTG 506406